BEGIN:VCALENDAR
VERSION:2.0
PRODID:-// - ECPv4.7.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.mdtechcouncil.com/membership/events
X-WR-CALDESC:Events for 
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230823T110000
DTEND;TZID=America/New_York:20230823T120000
DTSTAMP:20260503T214003
CREATED:20230816T115444Z
LAST-MODIFIED:20230816T115444Z
UID:3972-1692788400-1692792000@www.mdtechcouncil.com
SUMMARY:NCI Technology Opportunities Webinar: GPC1 as a New Therapeutic Target in Pancreatic Cancer: Development of Antibodies and CAR-T
DESCRIPTION:Register to attend a free NIH webinar. Attendees will learn about a new targeted immunotherapy pancreatic cancer treatment centered on the Glypican-1 (GPC1) cell surface heparan sulfate proteoglycan protein which is overexpressed in pancreatic cancer. The webinar will be presented by Dr. Mitchell Ho\, Deputy Chief\, NCI Laboratory of Molecular Biology. \nWebinar overview: The inventors will discuss the development of their novel Chimeric Antigen Receptors (CARs) specific for GPC1 that include short Immunoglobulin subclass 4 (IgG4) hinge sequences between the extracellular antigen recognition domain and the transmembrane domain. Hinge changes in CAR design can achieve the threshold of antigen density required for optimal CAR-T cell activity. Specifically\, the optimized GPC1-IgG4 hinge CARs show rapid and complete tumor regression in mouse models. \n
URL:https://www.mdtechcouncil.com/membership/events/calendar/nci-technology-opportunities-webinar-gpc1-as-a-new-therapeutic-target-in-pancreatic-cancer-development-of-antibodies-and-car-t/
LOCATION:Virtual Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230823T110000
DTEND;TZID=America/New_York:20230823T120000
DTSTAMP:20260503T214003
CREATED:20230921T154217Z
LAST-MODIFIED:20230921T154217Z
UID:3999-1692788400-1692792000@www.mdtechcouncil.com
SUMMARY:NCI Technology Opportunities Webinar: GPC1 as a New Therapeutic Target in Pancreatic Cancer: Development of Antibodies and CAR-T
DESCRIPTION:Updated Registration Link:  https://cbiit.webex.com/weblink/register/rd3e62547e5223e106861c6ec6ff496a6 \nRegister to attend a free NIH webinar. Attendees will learn about a new targeted immunotherapy pancreatic cancer treatment centered on the Glypican-1 (GPC1) cell surface heparan sulfate proteoglycan protein which is overexpressed in pancreatic cancer. The webinar will be presented by Dr. Mitchell Ho\, Deputy Chief\, NCI Laboratory of Molecular Biology. \nWebinar overview: The inventors will discuss the development of their novel Chimeric Antigen Receptors (CARs) specific for GPC1 that include short Immunoglobulin subclass 4 (IgG4) hinge sequences between the extracellular antigen recognition domain and the transmembrane domain. Hinge changes in CAR design can achieve the threshold of antigen density required for optimal CAR-T cell activity. Specifically\, the optimized GPC1-IgG4 hinge CARs show rapid and complete tumor regression in mouse models. \n
URL:https://www.mdtechcouncil.com/membership/events/calendar/nci-technology-opportunities-webinar-gpc1-as-a-new-therapeutic-target-in-pancreatic-cancer-development-of-antibodies-and-car-t-2/
LOCATION:Virtual Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230823T183000
DTEND;TZID=America/New_York:20230823T203000
DTSTAMP:20260503T214003
CREATED:20230717T150803Z
LAST-MODIFIED:20230717T150803Z
UID:3900-1692815400-1692822600@www.mdtechcouncil.com
SUMMARY:Design Thinking for Entrepreneurs
DESCRIPTION:\n\n\n\nDon’t just speculate. Design it. \nThis four-part seminar held Wednesday evenings from August 23- September 13\, will give you the tools you need to cut through ambiguity and move forward with confidence. Vance MacEwen\, co-founder of Greatest Possible Good\, delivers interactive workshops taking you through the design thinking process. \nYou’re not just taking another class; thanks to a generous Howard County grant\, you will have free access to your instructors’ calendars while taking courses at the MIC. Apply what you learn in real-time. \nIn this series you will: \n\nLearn what design thinking is and how you can use it to build what your customers actually want\, not just what you think they want\nPractice customer interviews\, collaborative research synthesis\, rapid prototyping\, and user testing in a fun\, low-stakes way before carrying it out for your own venture\nCheck in with your instructor with free one-on-ones as you apply your new tools\n\nWhen you are done with the program\, you will have a powerful new toolkit setting you apart from your competition and giving you a greater measure of certainty. \nPlease note it is highly encouraged to attend all four sessions\, as they go through the design thinking process in a sequence. \nAbout our presenter: Vance MacEwen\, MA\, MBA – Entrepreneur in Residence at the Maryland Innovation Center (MIC) and co-founder CEO of Greatest Possible Good\, a design thinking firm for social good. Vance mentors residents and affiliates of the MIC and volunteers through the Maryland Tech Council Venture Mentor Services\, SEED SPOT\, and the Youth Leaders of the Americas Initiative. Greatest Possible Good\, winner of the 2019 MICA UP/Start Venture Competition\, works with social entrepreneurs\, nonprofits\, and small businesses to align teams and executives’ actions with their visions for impact. Vance previously served as chief of staff for Montgomery County Delegate Al Carr\, English teacher at a private school in Chengdu\, China\, and work crew member at McDonogh School. He loves helping founders find their North Stars\, hone their business strategies\, and win pitches. He is a certified Kauffman FastTrac facilitator. \nRegistration closes on August 22 \n\n\n\n\n
URL:https://www.mdtechcouncil.com/membership/events/calendar/design-thinking-for-entrepreneurs-6/
LOCATION:Maryland Innovation Center (MIC) 6751 Columbia Gateway Drive 3rd Floor\, Training Room Columbia\, MD 21046
END:VEVENT
END:VCALENDAR